Agilent Receives FDA Approval for Mage-a4 Ihc 1F9 Pharmdx as a Diagnostic Tool for Use With Newly Approved Tcr T-Cell Therapy
愛捷獲得FDA批准,將Mage-a4 Ihc 1F9 Pharmdx作爲新獲批的TCR T細胞療法的診斷工具。
Agilent Receives FDA Approval for Mage-a4 Ihc 1F9 Pharmdx as a Diagnostic Tool for Use With Newly Approved Tcr T-Cell Therapy
愛捷獲得FDA批准,將Mage-a4 Ihc 1F9 Pharmdx作爲新獲批的TCR T細胞療法的診斷工具。
譯文內容由第三人軟體翻譯。